Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary - PubMed (original) (raw)
Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
N Ravindranath et al. Endocrinology. 1992 Jul.
Abstract
We studied the distribution of messenger RNA (mRNA) that encodes for vascular endothelial growth factor (VEGF) within the primate ovary by in situ hybridization and Northern analysis to determine if the presence of mRNA for this angiogenic factor is associated with structures within the ovary in which angiogenesis is thought to play a role in development and/or function. In situ hybridization to sections of cynomolgus ovaries with a 35S-labeled antisense RNA probe revealed specific tissue localization within the follicle as well as the corpus luteum, but not stromal tissue. Intense expression of mRNA for VEGF during the late follicular phase was confined to the maturing follicle which, we presume, was destined for ovulation. Hybridization within the corpus luteum exhibited a punctate pattern suggesting that there may be specific cells within the corpus luteum that express mRNA for VEGF. The expression of mRNA for VEGF during the early and late luteal phase of the menstrual cycle was studied by Northern analysis. Messenger RNAs were detectable at approximately 3.7 and 5.0 kb positions in corpora lutea collected during the early luteal phase of the menstrual cycle (days 3-5 postovulation). No hybridization signals were observed with RNA prepared from regressing corpora lutea (1-2 days following the onset of menses). The gonadotropic regulation of the expression of mRNA for VEGF in the corpus luteum was studied by treating monkeys with a potent GnRH antagonist during the midluteal phase of the menstrual cycle. Administration of the antagonist for 1 or 2 days did not alter the expression of mRNA for VEGF in comparison to corresponding controls. However, a 3-day treatment regimen brought about a significant reduction in the levels of mRNA for VEGF (P less than 0.01). These studies demonstrate a development-related expression of mRNA for VEGF in the ovary during the menstrual cycle and are consistent with the hypothesis that VEGF may play important roles in follicle selection and corpus luteum function in primates.
Similar articles
- Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells.
Laitinen M, Ristimäki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Laitinen M, et al. Endocrinology. 1997 Nov;138(11):4748-56. doi: 10.1210/endo.138.11.5500. Endocrinology. 1997. PMID: 9348202 - Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
Al-zi'abi MO, Watson ED, Fraser HM. Al-zi'abi MO, et al. Reproduction. 2003 Feb;125(2):259-70. Reproduction. 2003. PMID: 12578540 - Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid.
Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM. Wulff C, et al. J Clin Endocrinol Metab. 2000 Nov;85(11):4302-9. doi: 10.1210/jcem.85.11.6942. J Clin Endocrinol Metab. 2000. PMID: 11095472 - Role of vascular endothelial growth factor in ovarian physiology - an overview.
Kaczmarek MM, Schams D, Ziecik AJ. Kaczmarek MM, et al. Reprod Biol. 2005 Jul;5(2):111-36. Reprod Biol. 2005. PMID: 16100562 Review. - Regulation and action of angiogenic factors in the primate ovary.
Stouffer RL, Martínez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Stouffer RL, et al. Arch Med Res. 2001 Nov-Dec;32(6):567-75. doi: 10.1016/s0188-4409(01)00323-x. Arch Med Res. 2001. PMID: 11750732 Review.
Cited by
- Significance and Influence of Suturing for Ovarian Tissue Transplantation.
Kanamori R, Takae S, Ito K, Mukae A, Shimura M, Suzuki N. Kanamori R, et al. Reprod Sci. 2024 Jan;31(1):162-172. doi: 10.1007/s43032-023-01320-x. Epub 2023 Sep 6. Reprod Sci. 2024. PMID: 37674005 - Age-related changes in Folliculogenesis and potential modifiers to improve fertility outcomes - A narrative review.
Esencan E, Beroukhim G, Seifer DB. Esencan E, et al. Reprod Biol Endocrinol. 2022 Nov 17;20(1):156. doi: 10.1186/s12958-022-01033-x. Reprod Biol Endocrinol. 2022. PMID: 36397149 Free PMC article. Review. - New markers for regulation of transcription and macromolecule metabolic process in porcine oocytes during in vitro maturation.
Brązert M, Kranc W, Nawrocki MJ, Sujka-Kordowska P, Konwerska A, Jankowski M, Kocherova I, Celichowski P, Jeseta M, Ożegowska K, Antosik P, Bukowska D, Skowroński MT, Bruska M, Pawelczyk L, Zabel M, Piotrowska-Kempisty H, Nowicki M, Kempisty B. Brązert M, et al. Mol Med Rep. 2020 Mar;21(3):1537-1551. doi: 10.3892/mmr.2020.10963. Epub 2020 Jan 27. Mol Med Rep. 2020. PMID: 32016446 Free PMC article. - The Role of Growth Hormone on Ovarian Functioning and Ovarian Angiogenesis.
Devesa J, Caicedo D. Devesa J, et al. Front Endocrinol (Lausanne). 2019 Jul 16;10:450. doi: 10.3389/fendo.2019.00450. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379735 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources